Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.3K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.6K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

1.7K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.7K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

2.9K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcome after distal vascular reconstruction in women.

Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing·1999
Same author

The quality of life of the limb-threatened patient after lower-extremity revascularization.

Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing·1996
Same journal

Effectiveness of Nurse-Led Telemonitoring Versus Usual Care on Readmission and Mortality Rates in Patients With Chronic Heart Failure: A Meta-Analysis.

The Journal of cardiovascular nursing·2026
Same journal

Contemporary Lipid Guidelines: Key Updates and Implications for Cardiovascular Nurses.

The Journal of cardiovascular nursing·2026
Same journal

The Interplay Between Physical Symptoms, Benefit Finding, Patient Activation, Social Support, Family Function, and Hope in Patients With Heart Failure: A Network Analysis.

The Journal of cardiovascular nursing·2026
Same journal

Self-Care, Treatment Adherence, and Frailty in Older Adults With Hypertension: A Descriptive Correlational Study.

The Journal of cardiovascular nursing·2026
Same journal

Predictors of Prolonged Intensive Care Unit Stay After Heart Valve Surgery: A Case-Control Study.

The Journal of cardiovascular nursing·2026
Same journal

Characteristics and Care Practices in People Hospitalized for Heart Failure With Coexisting Diabetes: A Single-Center Retrospective Observational Study.

The Journal of cardiovascular nursing·2026
See all related articles

Related Experiment Video

Updated: Mar 11, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

830

Renovascular hypertension.

K R Bruni1

  • 1Institute for Vascular Health and Disease, Albany Medical College, New York, USA.

The Journal of Cardiovascular Nursing
|June 23, 2001
PubMed
Summary
This summary is machine-generated.

Renovascular hypertension requires prompt diagnosis and management due to its serious prognosis and risk of kidney failure. Treatment options include medical therapy, angioplasty, stenting, or revascularization, with ongoing blood pressure monitoring crucial.

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.3K
A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

5.7K

Related Experiment Videos

Last Updated: Mar 11, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

830
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.3K
A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

5.7K

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension Management

Background:

  • Renovascular hypertension (RVH) presents unique challenges compared to essential hypertension.
  • Delayed diagnosis of RVH can lead to a poorer prognosis and irreversible kidney damage.
  • RVH increases the risk of developing accelerated or malignant hypertension.

Purpose of the Study:

  • To outline the pathophysiologic features of renovascular hypertension.
  • To detail diagnostic strategies for identifying renovascular hypertension.
  • To review current treatment and management approaches for patients with renovascular hypertension.

Main Methods:

  • Discussion of pathophysiologic mechanisms.
  • Review of diagnostic criteria and methods.
  • Analysis of therapeutic interventions including medical, endovascular, and surgical options.

Main Results:

  • Early detection of RVH is critical for better patient outcomes.
  • RVH is less responsive to standard drug treatments than essential hypertension.
  • Treatment modalities encompass medical management, angioplasty with or without stenting, and surgical revascularization.

Conclusions:

  • Renovascular hypertension necessitates a comprehensive management strategy.
  • Integrated nursing care, particularly blood pressure follow-up, is vital for successful patient management.
  • Timely intervention can mitigate the risks of progressive kidney damage and severe hypertensive complications.